Status:
UNKNOWN
Leukocyte Esterase Sensor Test
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to assess the diagnostic efficacy of the quantitative electrochemical LE biosensor for periprosthetic joint infection (PJI). The secondary objective of this stud...
Eligibility Criteria
Inclusion
- 1: consecutive patients undergoing at least one of the following procedures: presumed aseptic revision arthroplasty, irrigation and debridement, radical resection for periprosthetic joint infection
Exclusion
- known active gout flare
- existing corrosion or metallosis
- inflammatory arthritis
- preexisting diagnosis of infection in the same joint
- patients undergoing second-stage procedure for infection.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04390607
Start Date
November 1 2020
End Date
October 31 2021
Last Update
September 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10003